Trends in the choice of antiseizure medications in juvenile myoclonic epilepsy: A retrospective multi-center study from Turkey between 2010 and 2020

Kilic B., SERDAROĞLU E., Polat B. G., Ince T., ESENÜLKÜ G., Topcu Y., ...Daha Fazla

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, cilt.99, ss.48-53, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 99
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1016/j.seizure.2022.05.005
  • Dergi Adı: SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE, Psycinfo
  • Sayfa Sayıları: ss.48-53
  • Anahtar Kelimeler: juvenile myoclonic epilepsy, valproic acid, levetiracetam, LEVETIRACETAM, VALPROATE, MONOTHERAPY, MANAGEMENT
  • Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Purpose:Valproic acid (VPA) is frequently used and effective in juvenile myoclonic epilepsy (JME). Recently, levetiracetam (LEV) has been suggested as a monotherapy in JME. This study aimed to evaluate antiseizure medication (ASM) use in patients with JME.